[September 30, 2005] Telzuit Medical Technologies Announces New Patent Filing for Monitoring Device for Nursing Home / Assisted Living Facility Patients Tweet ORLANDO, Fla. --(Business Wire)-- Sept. 30, 2005 -- Telzuit Medical Technologies, Inc. (the "Company" or "Telzuit") (OTCBB:TZMT) announced today that the Company has filed for provisional patents with the US Patent & Trademark Office for a new monitoring device utilizing the Company's BioPatch platform. The new device, developed by the Company's Senior Vice President of Product Development, Michael Vosch, is intended for use in nursing homes and assisted living facilities. The Company expects to have all of the necessary modifications made to its production model within a short period of time and be able to market the new product in 2006. In addition to providing basic biometric data on patients, the Company anticipates that it will also be able to detect if a patient has fallen. Once fully developed, by utilizing the BioPatch platform, the patient's data can be relayed to either a PDA or a PC enabling caregivers to monitor more patients with better efficiency. Donald Sproat, CEO and President of Telzuit Medical Technologies, Inc. said, "Those of us with the Company are very excited about the possibility that our new technology will be available for use by assisted living and nursing home patients in 2006. With over 1.8 million nursing home beds and over 1.2 million assisted living facility beds already in existence in the United States, we expect our new device to have a real impact on the quality of care in each of these instances as we provide better tools for health care providers to use." About Telzuit Medical Technologies, Inc. Telzuit Medical Technologies, Inc. and its wholly owned subsidiary Telzuit Technologies, Inc. are dedicated to providing advanced mobile medicine for people worldwide. The first step in this mission will initially take the form of our state-of-the-art, FDA approved, Bio-Patch Wireless Heart Monitor. This is a full 12-lead, completely wireless, Holter monitor, which is new to the marketplace. Telzuit anticipates that the product will be available to patients and physicians during the 2005 calendar year. Telzuit is also building its own dedicated intranet as a platform to handle several of the products it will be releasing, including its initial product, the Bio-Patch Wireless Heart Monitor. More information on Telzuit, its business model, and its products can be found on its website: http://www.telzuit.com. The corporate offices of Telzuit are located at 5422 Carrier Drive, Suite 306, Orlando, FL 32819. Questions may be addressed to James Tolan, Senior Vice President of Business Development, at 407-354-1222. Forward Looking Statement: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release. [ Back To TMCnet.com's Homepage ]